Thyrocare Technologies Limited, a leading diagnostic services provider, has announced multiple shareholder-friendly measures as part of its 25th anniversary celebrations. These include a 2:1 bonus share issue, an interim dividend, and strong Q2 financial results, highlighting the company’s healthy performance and growth outlook.
For the quarter ended September 30, Thyrocare reported a solid set of numbers, reinforcing its leadership in the diagnostics space.
| Metric | Amount (₹ in crore) |
| Revenue from Operations | 202.23 |
| Profit | 43.03 |
The results reflect consistent demand for diagnostic services and operational efficiency across the company’s nationwide network.
The Board of Directors has approved a bonus issue in the ratio of 2:1, meaning shareholders will receive two new shares for every one share held, subject to shareholder approval.
This move aims to enhance share liquidity and reward long-term investors. The record date for determining eligible shareholders will be announced later.
Along with the bonus issue, Thyrocare has declared an interim dividend of Rs 7 per equity share, equivalent to 70% of the face value. The record date for this dividend is October 24, 2025.
Thyrocare Tech share price has delivered robust returns, rising over 77% in the past six months and 54% in the last year, reflecting strong investor confidence.
| Period | Return |
| 1 Day | +0.24% |
| 5 Days | +3.74% |
| 1 Month | +6.29% |
| 6 Months | +77.25% |
| 1 Year | +53.99% |
| 5 Years | +20.36% |
Thyrocare’s 2:1 bonus issue and interim dividend come as a celebratory gesture for its 25th year, reaffirming its commitment to shareholder value. With strong financials and expanding market reach, the company continues to be a standout performer in India’s diagnostics industry.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: Oct 14, 2025, 4:41 PM IST
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN